NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
16.60
-0.05 (-0.30%)
Oct 19, 2026, 12:39 PM EDT - Market open
NeoGenomics Market Cap
NeoGenomics has a market cap or net worth of $2.13 billion as of October 19, 2026. It is the 6,365th most valuable company in the world and the 1,708th biggest in the United States. Its market cap has increased by 64.28% in one year.
Market Cap
2.13B
Enterprise Value
2.44B
1-Year Change
64.28%
Global Rank
Country Rank
#1,708 United States
Category
ChartMarket Cap Chart
Since March 16, 2004, NeoGenomics's market cap has increased from $7.90M to $2.13B, an increase of 26,896.11%. That is a compound annual growth rate of 28.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 2.13B | 40.16% |
| Dec 31, 2025 | 1.52B | -28.07% |
| Dec 31, 2024 | 2.12B | 2.57% |
| Dec 29, 2023 | 2.06B | 76.73% |
| Dec 30, 2022 | 1.17B | -72.22% |
| Dec 31, 2021 | 4.20B | -29.72% |
| Dec 31, 2020 | 5.98B | 95.74% |
| Dec 31, 2019 | 3.05B | 160.37% |
| Dec 31, 2018 | 1.17B | 64.64% |
| Dec 29, 2017 | 712.40M | 5.87% |
| Dec 30, 2016 | 672.90M | 41.66% |
| Dec 31, 2015 | 475.00M | 89.92% |
| Dec 31, 2014 | 250.10M | 41.06% |
| Dec 31, 2013 | 177.30M | 57.88% |
| Dec 31, 2012 | 112.30M | 85.62% |
| Dec 30, 2011 | 60.50M | 24.49% |
| Dec 31, 2010 | 48.60M | -12.90% |
| Dec 31, 2009 | 55.80M | 189.12% |
| Dec 31, 2008 | 19.30M | -43.07% |
| Dec 31, 2007 | 33.90M | -16.30% |
| Dec 29, 2006 | 40.50M | 841.86% |
| Dec 30, 2005 | 4.30M | -20.37% |
| Dec 31, 2004 | 5.40M | -31.65% |
| Mar 16, 2004 | 7.90M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GRAIL | 5.26B |
| Sotera Health Company | 5.11B |
| BillionToOne | 4.63B |
| Adaptive Biotechnologies | 3.83B |
| Veracyte | 3.47B |
| CareDx | 3.31B |
| GeneDx Holdings | 1.90B |
| Personalis | 1.67B |